The rules of the New York Stock Exchange (NYSE) and the Nasdaq Stock Market (Nasdaq) require that a majority of a listed company’s board of directors (board) must be comprised of.
Between Dandelions, Inc. Announces Merger with Optimus Healthcare Services, Inc.
NEW YORK, NY / ACCESSWIRE / December 29, 2020 / Between Dandelions Inc (OTC PINK:HOPS) announced today the closing of a merger with Optimus Healthcare Services, Inc. ( Optimus or Company ).
Optimus, a company formed in 2020, controlled by KORR Acquisitions Group, Inc. ( KORR ), recently acquired control of Clinical Research Alliance, Inc. ( CRA ). Optimus was a portfolio company of KORR and as of the closing, KORR is now the controlling shareholder of Between Dandelions Inc. Between Dandelions Inc. will change its name to Optimus Healthcare Services Inc.
Optimus will focus on healthcare-related services.
The Company has appointed a new CEO, Marc Wiener. Prior to joining Optimus, Mr. Wiener was the founder of Orphan Pharmacy Services, which was sold in 2020, the co-founder of Linden Care Services, which sold to Belhealth Investment Partners in 2013, and Vitality Pharmaceutical Services, which sold t
Between Dandelions, Inc. Announces Merger with Optimus Healthcare Services, Inc.
NEW YORK, NY / ACCESSWIRE / December 29, 2020 / Between Dandelions Inc (OTC PINK:HOPS) announced today the closing of a merger with Optimus Healthcare Services, Inc. ( Optimus or Company ).
Optimus, a company formed in 2020, controlled by KORR Acquisitions Group, Inc. ( KORR ), recently acquired control of Clinical Research Alliance, Inc. ( CRA ). Optimus was a portfolio company of KORR and as of the closing, KORR is now the controlling shareholder of Between Dandelions Inc. Between Dandelions Inc. will change its name to Optimus Healthcare Services Inc.
Optimus will focus on healthcare-related services.
The Company has appointed a new CEO, Marc Wiener. Prior to joining Optimus, Mr. Wiener was the founder of Orphan Pharmacy Services, which was sold in 2020, the co-founder of Linden Care Services, which sold to Belhealth Investment Partners in 2013, and Vitality Pharmaceutical Services, which sold t